Analysis of clonal cell growth using X-chromosome inactivation patterns

Onkologie

Volumn 21, Issue 5, 1998, Pages 380-386

  Mannhalter, C ^a   Mitterbauer, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Clonality analysis; Hematologic malignancies; Neoplasias; X chromosome inactivation

Indexed keywords

BLOOD DISEASE; CELL CLONE; CELL GROWTH; CHROMOSOME ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENE MAPPING; HUMAN; MASS SCREENING; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; REVIEW; X CHROMOSOME INACTIVATION;

EID: 0031730163     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026860     Document Type: Review

References (54)

1. Heard E, Avner P. Role play in X-inactivation. Hum Mol Genet 1994;3:1481-1485
2. Vogelstein B, Fearon ER, Hamilton SR, Feinberg AP: Use of restriction fragment length polymorphism to determine the clonal origin of human tumors. Science 1985;227:642-645.
3. Turhan AG, Humphries RK, Phillips GL, Eaves AC, Eaves CJ: Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation N Engl J Med 1989;320:1655-1661.
4. Hodges E, Howell WM, Boyd Y, Smith JL: Variable X-chromosome DNA methylation patterns detected with probe M27β in a series of lymphoid and myeloid malignancies. Br J Haematol 1991;77:315-322.
5. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF: Clonality in myeloproliferative disorders: Analysis by means of polymerase chain reaction. Proc Natl Acad Sci USA 1991;88:6848-6852.
6. Gale RE, Linch DC: Investigation of methylation at HhaI sites using the hypervariable probe M27β allows improved clonal analysis in myeloid leukemia and demonstrates differences in methylation between leukemic and remission samples. Leukemia 1994;8:190-194.
7. Delabesse E, Aral S, Kamoun P, Varet B, Turhan AG: Quantitative non-radioactive clonality analysis of human leukemic cells and progenitors using the human androgen receptor (AR) gene. Leukemia 1995;9:1578-1582
8. Bonsing BA, Devilee P, Cleton Jansen AM, Kuipers-Dijkshoom N, Fleuren GJ, Cornelisse CJ: Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas. Cancer Res 1993;53:3804-3811.
9. Willman CL, Busque L, Griffith B, Favara BE, Mc Clain KL, Duncan MH, Gilliland DG: Langerhans' cell histiocytosis (histiocytosis X) - a clonal proliferative disorder N Engl J Med 1994;331:154-160.
10. Walsh DS, Tsou HC, Harrington A, James WD, Peacocke M: Clonality of basal cell carcinoma - Molecular analysis of an interesting case. J Invest Dermatol 1996;106:579-582.
11. Jovanovic AS, Boynton KA, Mutter GL: Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability. Cancer Res 1996;56:1917-1921.
12. Mutter GL, Chaponot ML, Fletcher JA: A polymerase chain reaction assay for nonrandom X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol 1995;146:501-508.
13. Gale RE, Wheadon H, Linch DC: Assessment of X-chromosome inactivation patterns using the hypervariable probe M27β in normal hematopoietic cells and acute myeloid leukemia blasts. Leukemia 1992;6:649-655.
14. Dow LW, Martin P, Moohr J, Greenberg M, Macdougall LG, Najfield V, Fialkow PJ: Evidence for clonal development of childhood acute lymphoblastic leukemia Blood 1985;66:902-907
15. Fialkow P, Gartler SM, Yoshida A: Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 1967;58:1468-1471.
16. Fialkow JP, Faguet GB, Jacobson RJ, Vaidya K, Murphy S: Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981;58:916-919.
17. El Kassar N, Hetet O, Li Y, Briere J, Grandchamp B: Clonal analysis of haemopoietic cells in essential thrombocythaemia. Br J Haematol 1995;90:131-137.
18. Janssen JWG, Buschle M, Layton BM, Drexler HG, Lyons J, van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ, Bartram CR: Clonal analysis of myelodysplastic syndromes: Evidence of multipotent stem cell origin. Blood 1989;73:248-254.
19. Trefferi A, Thibodeau SN, Solberg LA: Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990;75:1770-1773
20. Culligan DJ, Cachia P, Whittaker J, Jacobs A, Padua RA: Clonal lymphocytes are detectable in only some cases of MD8. Br J Haematol 1992;81: 346-352.
21. Linder D, Gartler SM: Glucose-6-phosphate dehydrogenase mosaicism: Utilization as a cell marker in the study of leiomyomas. Science 1965;150:67-69.
22. Busque L, Zhu J, DeHart D, Griffith B, Willman C, Carioll R, McL Black P, Gilliland DG: An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. Nucleic Acids Res 1994;22:697-698.
23. Prchal JT, Liu Y, Prchal JF, Hoffman R, Tushinski R: Are normal stem cells present in myeloproliferative syndrome? Blood 1994;84:207(abstract).
24. El-Kassar N, Hetet G, Briere J, Grandchamp B: Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets Blood 1997;89:128-134.
25. Fialkow PJ: Clonal origin of human tumors. Biochim Biophys Acta 1976;458:283-321.
26. Vogelstein B, Rearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, Riggs AD, Orkin SH: Clonal analysis using recombinant DNA probes from the X-chromosome Cancer Res 1987;47:4806-4813.
27. Fey MF, Liechti-Gallati S, von Rohr A, Borisch B, Theilkäs L, Schneider V, Oestreicher M, Nagel S, Ziemiecki A, Tobler A: Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27beta DNA probe. Blood 1994;83:931-938.
28. Fraser NJ, Boyd Y, Brownlee GG, Craig IW: Multiallelic RFLP for M27β, an anonymous single copy genomic clone at Xp11.3-Xcen (HMG9 provisional no. DXS255). Nucleic Acids Res 1987;15:9616.
29. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79.
30. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R: Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups Genomics 1992;12:241-253.
31. Allen RC, Zoghbi HY, Mosley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet 1992;51:1229-1239.
32. Abrahamson G, Boultwood J, Madden J, Kelly S, Oscier DG, Rack K, Buckle V, Wainscoat J: Clonality of cell populations in refractory anemia using combined approach of gene loss and X-linked restriction length polymorphism - Methylation analyses. Br J Haematol 1991;79:550-555.
33. Lucas GS, Padua RA, Masters GS, Oscier DG, Jacobs A: The application of X-chromosome gene probes to the diagnosis of myeloproliferative disease. Br J Haematol 1989;72:530-533.
34. Tsukamoto N, Morita K, Maehara T, Okamoto K, Sakai H, Karasawa M, Naruse T, Omine M: Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: Demonstration of heterogeneity of lineage involvement. Br J Haematol 1994;86:253-258.
35. Kreipe H, Jaquet K, Felgner J, Parwaresch MR: Clonal analysis of agnogenic myeloid metaplasia. Leuk Lymphoma 1992;8:459-464.
36. Fialkow PJ: Primordial cell pool size and lineage relationships of five human cell types. Ann Hum Genet 1973;37:39-48.
37. Gale RE, Wheadon H, Boulos P, Linch DC: Tissue specificity of X-chromosome inactivation patterns. Blood 1994;83:2899-2905.
38. Brown RM, Fraser NJ, Brown GK: Differential methylation of the hypervariable locus DXS255 on active and inactive X chromosome correlates with the expression of a human X-linked gene. Genomics 1990;7:215-221.
39. Fey MF, Peter HJ, Hinds HL, Zimmermann A, Liechti-Gallati S, Gerber H, Studer H, Tobler A: Clonal analysis of human tumors with M27β, a highly informative polymorphic X chromosomal probe J Clin Invest 1992;89:1438-1444.
40. Champion KM, Gilbert JGR, Asimakopoulos FA, Hinshelwood S, Green AR: Clonal haemopoiesis in normal elderly women. Implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol 1997;97:920-926.
41. Bonsing BA, Devilee P, Cleton-Jansen, Kuipers-Dijkshoom N, Fleuren GJ, Cornelisse CJ: Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas. Cancer Res 1993;53:3804-3811
42. Sidransky D, Frost P, von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B: Clonal origin of bladder cancer. N Engl J Med 1992;326:737-740.
43. Mashal RD, Lester SC, Sklar J: Clonal analysis by study of X chromosomal inactivation in formalin-fixed paraffin embedded tissue. Cancer Res 1993;53:4676-4679.
44. Gaffney MJ, Iezzoni JC, Weiss LM: Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996;148:1089-1096.
45. Gale RE, Wheadon H, Linch DC: X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and postchemotherapy females. Br J Haematol 1991;79:193-197.
46. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, Maragh M, Gilliland DG Nonrandom X-inactivation patterns in normal females: Ljonization ratios vary with age. Blood 1996;88:59-65.
47. Brown RM, Brown GK: X chromosome inactivation and the diagnosis of X-linked disease in females J Med Genet 1993;30:177-184.
48. Naumova AK, Plenge RM, Bird LM, Leppert M, Morgan K, Willard HF, Sapienza C: Heritability of X chromosome-inactivation phenotype in a large family Am J Hum Genet 1996;58:1111-1119.
49. Pegoraro E, Whitaker J, Mowery-Rushton P, Surti U, Lanasa M, Hoffman EP: Familial skewed X inactivation: A molecular trait associated with high spontaneous abortion rate maps to Xq28. Am J Hum Genet 1997;61:160-170.
50. Conley ME, Brown P, Pichard AR, Buckley RH, Miller DS, Raskin WH, Singer JW, Fialkow PJ: Expression of the gene defect in X-linked agammaglobulinemia. N Eng J Med 1986;315:564-567.
51. Fearon ER, Koher DB, Winkelstein JA, Vogelstein B, Blasse RM: Carrier detection in the Wiskott-Aldrich syndrome Blood 1988;72:1735-1739.
52. Allen CR, Nachtman RG, Rosenblatt HM, Belmont JW: Application of carrier testing to genetic counseling for X-linked agammaglobulinemia. Am J Hum Genet 1994;54:25-35
53. Puck JM, Stewart CC Nussbaum RL: Maximum likelihood analysis of human T-cell X chromosome inactivation patterns: Normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet 1992;50:742-748.
54. Devriendt K, Matthijs G, Legius E, Schollen E, Blockmans D, van Geet C, Degreef H, Cassiman JJ, Fryns JP: Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am J Hum Genet 1997;60:581-587.